Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Haller

Showing results (321-330 of 363) with videos related to

Pageof 37
Sort By:
Advanced Functional Materials|March 28, 2013
A biologically active surface enzyme assembly that attenuates thrombus formationZheng Qu, Sharmila Muthukrishnan, Murali K Urlam, et al.
Ophthalmology|July 19, 2011
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsJulia A Haller, Francesco Bandello, Rubens Belfort, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
Ophthalmology|April 27, 2010
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionJulia A Haller, Francesco Bandello, Rubens Belfort, et al.
Ophthalmology|April 1, 2014
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS studyJeffrey S Heier, W Lloyd Clark, David S Boyer, et al.
American Journal of Ophthalmology|April 3, 2004
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesisElia J Duh, Hoseong S Yang, Julia A Haller, et al.
The British Journal of Ophthalmology|January 29, 2009
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaD V Do, Q D Nguyen, S M Shah, et al.
The British Journal of Ophthalmology|December 15, 2015
Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) studyMargaret A Greven, Sunir Garg, Bing Chiu, et al.
Cell Chemical Biology|December 30, 2020
Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteinsDiane D Park, Jiaxuan Chen, Matthew R Kudelka, et al.
Preventing Chronic Disease|May 20, 2021
A Randomized Trial to Improve Adherence to Follow-up Eye Examinations Among People With GlaucomaBenjamin E Leiby, Sarah E Hegarty, Tingting Zhan, et al.
Pageof 37

Showing results (321-330 of 363) with videos related to

Sort By:
Pageof 37
Advanced Functional Materials|March 28, 2013
A biologically active surface enzyme assembly that attenuates thrombus formationZheng Qu, Sharmila Muthukrishnan, Murali K Urlam, et al.
Ophthalmology|July 19, 2011
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study resultsJulia A Haller, Francesco Bandello, Rubens Belfort, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
Ophthalmology|April 27, 2010
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionJulia A Haller, Francesco Bandello, Rubens Belfort, et al.
Ophthalmology|April 1, 2014
Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS studyJeffrey S Heier, W Lloyd Clark, David S Boyer, et al.
American Journal of Ophthalmology|April 3, 2004
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesisElia J Duh, Hoseong S Yang, Julia A Haller, et al.
The British Journal of Ophthalmology|January 29, 2009
An exploratory study of the safety, tolerability and bioactivity of a single intravitreal injection of vascular endothelial growth factor Trap-Eye in patients with diabetic macular oedemaD V Do, Q D Nguyen, S M Shah, et al.
The British Journal of Ophthalmology|December 15, 2015
Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) studyMargaret A Greven, Sunir Garg, Bing Chiu, et al.
Cell Chemical Biology|December 30, 2020
Resident and elicited murine macrophages differ in expression of their glycomes and glycan-binding proteinsDiane D Park, Jiaxuan Chen, Matthew R Kudelka, et al.
Preventing Chronic Disease|May 20, 2021
A Randomized Trial to Improve Adherence to Follow-up Eye Examinations Among People With GlaucomaBenjamin E Leiby, Sarah E Hegarty, Tingting Zhan, et al.
Pageof 37